Moreover, a higher Lamin B1 expression level has been linked to increased cancer aggressiveness, such as in liver and pancreatic cancer [65,66], while in contrast, lower Lamin B1 is associated with poor prognosis and more aggressiveness in breast and lung cancers [67,68]. Here, LMNB1 is linked to familial pancreatic carcinoma.